The Effectiveness of Multi-Session FMT Treatment in Active Ulcerative Colitis Patients: A Pilot Study

The Effectiveness of Multi-Session FMT Treatment in Active Ulcerative Colitis Patients: A Pilot Study

The modification of the microbiome through fecal microbiota transplantation (FMT) is becoming a very promising therapeutic option for inflammatory bowel disease (IBD) patients. Our pilot study aimed to assess the effectiveness of multi-session FMT treatment in active ulcerative colitis (UC) patients...

Full description

Bibliographic Details
Main Authors:	Dorota Mańkowska-Wierzbicka, Marta Stelmach-Mardas, Marcin Gabryel, Hanna Tomczak, Marzena Skrzypczak-Zielińska, Oliwia Zakerska-Banaszak, Anna Sowińska, Dagmara Mahadea, Alina Baturo, Łukasz Wolko, Ryszard Słomski, Agnieszka Dobrowolska
Format:	Article
Language:	English
Published:	MDPI AG 2020-08-01
Series:	Biomedicines
Subjects:	fecal microbiota transplantation (FMT) inflammatory bowel disease (IBD) ulcerative colitis (UC) gut microbiota
Online Access:	https://www.mdpi.com/2227-9059/8/8/268

Similar Items

Fecal Microbiota Transplantation Controls Murine Chronic Intestinal Inflammation by Modulating Immune Cell Functions and Gut Microbiota Composition
by: Claudia Burrello, et al.
Published: (2019-05-01)

Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study
by: Jessica W. Crothers, et al.
Published: (2021-07-01)

Fecal Microbiota Transplant in Two Ulcerative Colitis Pediatric Cases: Gut Microbiota and Clinical Course Correlations
by: Andrea Quagliariello, et al.
Published: (2020-09-01)

Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models
by: Francesco Strati, et al.
Published: (2021-02-01)

An Oral FMT Capsule as Efficient as an Enema for Microbiota Reconstruction Following Disruption by Antibiotics, as Assessed in an In Vitro Human Gut Model
by: Cécile Verdier, et al.
Published: (2021-02-01)

Fecal microbiota transplant – a new frontier in inflammatory bowel disease
by: Sunkara T, et al.
Published: (2018-08-01)

Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients
by: Mario Matijašić, et al.
Published: (2016-04-01)

Analyzing the Safety and Efficacy of Fecal Microbiota Transplantations for Inflammatory Bowel Disease using Clostridium difficile Infection as a Reference
by: Chan, Cassie
Published: (2016)

Dilution as a Solution: Targeting Microbial Populations with a Simplified Dilution Strategy
by: Disha Bhattacharjee, et al.
Published: (2020-07-01)

Promising Treatment for Type 2 Diabetes: Fecal Microbiota Transplantation Reverses Insulin Resistance and Impaired Islets
by: Hui Wang, et al.
Published: (2020-01-01)

Microbiota Transplantation in an Antibiotic-Induced Bacterial Depletion Mouse Model: Reproducible Establishment, Analysis, and Application
by: Dai, Z., et al.
Published: (2022)

Jag kan! : Grundskolan behöver FMT
by: Frödin, Göran
Published: (2011)

MICROBIOME: THE MISSING LINK IN NEUROPSYCHIATRIC DISORDERS
by: Alper Evrensel, et al.
Published: (2017-01-01)

Does the Internet promote the unregulated use of fecal microbiota transplantation: a potential public health issue?
by: Segal JP, et al.
Published: (2018-05-01)

Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
by: Azimirad M, et al.
Published: (2020-09-01)

Inflammatory Bowel Disease Etiology: Current Knowledge
by: Kikut Justyna, et al.
Published: (2018-12-01)

Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study
by: Oliwia Zakerska-Banaszak, et al.
Published: (2021-01-01)

Commentary on key aspects of fecal microbiota transplantation in small animal practice
by: Chaitman J, et al.
Published: (2016-05-01)

Role of Probiotics in Modulating Human Gut Microbiota Populations and Activities in Patients with Colorectal Cancer—A Systematic Review of Clinical Trials
by: Adrianna Wierzbicka, et al.
Published: (2021-04-01)

The Super-Donor Phenomenon in Fecal Microbiota Transplantation
by: Brooke C. Wilson, et al.
Published: (2019-01-01)

Musikens möjligheter : FMT i skolan
by: Christiansen, Margot
Published: (2009)

FMT En resa till utveckling
by: Tsjutsjura, Aleksander
Published: (2014)

Fecal Microbiota Transplantation: A Potential Tool for Treatment of Human Female Reproductive Tract Diseases
by: Gianluca Quaranta, et al.
Published: (2019-11-01)

Planktonic and Sessile Artificial Colonic Microbiota Harbor Distinct Composition and Reestablish Differently upon Frozen and Freeze-Dried Long-Term Storage
by: Lea Bircher, et al.
Published: (2020-01-01)

The new era of treatment for obesity: evidence and expectations for gut microbiome transplantation
by: Thilini N Jayasinghe, et al.
Published: (2016-02-01)

Biological markers demonstrate utility and predictive value in inflammatory bowel disease
Published: (2016)

From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation
by: Carole Nicco, et al.
Published: (2020-04-01)

FMT – ur ett utvecklingsperspektiv
by: Wessman, Josefin
Published: (2013)

Development of Machine Learning Model to Predict the 5-Year Risk of Starting Biologic Agents in Patients with Inflammatory Bowel Disease (IBD): K-CDM Network Study
by: Youn I Choi, et al.
Published: (2020-10-01)

The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon?
by: Michela Roberto, et al.
Published: (2021-08-01)

Comparative Evaluation of Microbiota Engraftment Following Fecal Microbiota Transfer in Mice Models: Age, Kinetic and Microbial Status Matter
by: Tiphaine Le Roy, et al.
Published: (2019-01-01)

Fecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome
by: Avner Leshem, et al.
Published: (2019-06-01)

Microbiome in liver diseases
by: A. Link, et al.
Published: (2020-01-01)

Regulation of Oxygen Homeostasis at the Intestinal Epithelial Barrier Site
by: Špela Konjar, et al.
Published: (2021-08-01)

The PTPN22 C1858T (R620W) functional polymorphism in inflammatory bowel disease
by: Younes Zaid, et al.
Published: (2018-11-01)

Neutrophil Extracellular Traps in Inflammatory Bowel Disease: Pathogenic Mechanisms and Clinical TranslationSummary
by: Broc Drury, et al.
Published: (2021-01-01)

En stadig grund att stå på : Ett arbete med fokus på FMT och stabilitet
by: Gustafsson, Ann
Published: (2012)

The Intestinal Microbiota as a Reservoir and a Therapeutic Target to Fight Multi-Drug-Resistant Bacteria: A Narrative Review of the Literature
by: Andrea Aira, et al.
Published: (2019-10-01)

Alteration of Gut Microbiota in Carbapenem-Resistant Enterobacteriaceae Carriers during Fecal Microbiota Transplantation According to Decolonization Periods
by: Jin-Jae Lee, et al.
Published: (2021-02-01)

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
by: Israr Khan, et al.
Published: (2019-08-01)

Cannot write session to /tmp/vufind_sessions/sess_9hej1si58p0g9hk8s2jn7r10eu